Biomarker based targeting of the epichaperome as a novel therapeutic approach for Multiple Myeloma (MM)

被引：0

作者：

Lopes, Eloisi Caldas ^{[1
]}

Wang, Tai ^{[2
]}

Jayabalan, David ^{[3
]}

Monge, Jorge

Taldone, Tony ^{[2
]}

Contreras, Jorge ^{[1
,4
]}

Yip, Winnie ^{[1
]}

Panchal, Palak ^{[2
]}

Sharma, Sahil ^{[2
]}

Digwal, Chander ^{[2
]}

Chiosis, Gabriela ^{[2
]}

Niesvizky, Ruben ^{[4
]}

Guzman, Monica ^{[1
]}

机构：

[1] Weill Cornell Med, New York, NY USA

[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[3] New York Presbyterian, Weill Cornell Med, New York, NY USA

[4] New York Presbyterian Hosp, Weill Cornell Med, New York, NY USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期

关键词：

Biomarker; epichaperome; Hsp90;

D O I：

10.1016/j.clml.2019.09.208

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

FP-123

引用

页码：E126 / E126

页数：1

共 50 条

[1] Harnessing the Epichaperome As a Therapeutic Approach in Multiple Myeloma
Lopes, Eloisi Caldas
Wang, Tai
Jayabalan, David S.
Taldone, Tony
Monge, Jorge
Contreras, Jorge
Winnie, Yip
Trujillo, Vicenta
Palak, Panchal
Lombardi, Nicholas
Sahil, Sharma
Chander, Digwal
Coleman, Morton
Chiosis, Gabriela
Niesvizky, Ruben
Guzman, Monica L.
BLOOD, 2019, 134
[2] Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myeloma
Prabhala, R. H.
Fulciniti, M.
Pelluru, D.
Rashid, N.
Nigroiu, A.
Nanjappa, P.
Pai, C.
Lee, S.
Prabhala, N. S.
Bandi, R. L.
Smith, R.
Lazo-Kallanian, S. B.
Valet, S.
Raje, N.
Gold, J. S.
Richardson, P. G.
Daley, J. F.
Anderson, K. C.
Ettenberg, S. A.
Di Padova, F.
Munshi, N. C.
LEUKEMIA, 2016, 30 (02) : 379 - 389
[3] Targeting Tryptophan Metabolism in Multiple Myeloma Offers Novel Therapeutic Approach
Reinke, Julia Grace
Chaudhry, Kanita
Carlson, Louise
Peng, Peng
Petrusca, Daniela
Schorr, Christopher
Lee, Kelvin
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S197 - S197
[4] Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myeloma
R H Prabhala
M Fulciniti
D Pelluru
N Rashid
A Nigroiu
P Nanjappa
C Pai
S Lee
N S Prabhala
R L Bandi
R Smith
S B Lazo-Kallanian
S Valet
N Raje
J S Gold
P G Richardson
J F Daley
K C Anderson
S A Ettenberg
F Di Padova
N C Munshi
Leukemia, 2016, 30 : 379 - 389
[5] Targeting Ubiquitin Pathway: Novel Therapeutic Approaches for Multiple Myeloma
Ghannam-Shahbari, Dima
Brik, Ashraf
Saadi, Sahar
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S190 - S191
[6] Bcl6 as a Novel Therapeutic Target in Multiple Myeloma (MM)
Hideshima, Teru
Mitsiades, Constantine S.
Ikeda, Hiroshi
Chauhan, Dharminder
Raje, Noopur
Gorgun, Gullu
Fulciniti, Mariateresa
Cirstea, Diana
Perron, Giulia
Santo, Loredana
Hideshima, Ayaka
Podar, Klaus
Munshi, Nikhil C.
Richardson, Paul
Carrasco, Daniel R.
Anderson, Kenneth C.
BLOOD, 2009, 114 (22) : 124 - 124
[7] Targeting CD47 As a Novel Therapeutic Strategy in Multiple Myeloma
Muz, Barbara
Kusdono, Hubert D.
King, Justin
Kohnen, Daniel
Fiala, Mark A.
Vij, Ravi
Capoccia, Ben
Manning, Pamela T.
Salama, Noha Nabil
Azab, Abdel Kareem
BLOOD, 2017, 130
[8] Targeting HDAC6 Is a Novel Approach to Augment the Therapeutic Benefit of Bromodomain Inhibition in Multiple Myeloma
Carew, Jennifer S.
Espitia, Claudia M.
Zhao, Weiguo
Kelly, Kevin R.
Nawrocki, Steffan T.
BLOOD, 2014, 124 (21)
[9] Targeting androgen receptor signaling in glioblastoma: A novel biomarker and therapeutic approach
Mason, Sofia
Chung, Sylvia
Juan, Beatriz Perez San
McCool, Cerys
Day, Bryan
Milioli, Heloisa Zaccaron
Dear, Rachel Fitz-Gerald
Sim, Hao-Wen
Holst, Jeff
Chaffer, Christine Louise
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[10] Novel therapeutic strategies targeting growth factor signalling cascades in multiple myeloma
Yasui, H
Hideshima, T
Richardson, PG
Anderson, KC
BRITISH JOURNAL OF HAEMATOLOGY, 2006, 132 (04) : 385 - 397

← 1 2 3 4 5 →